XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Passive income strategies can provide financial stability. Learn how to use index funds to create a reliable income stream.
21,140 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Asian markets fall as energy prices surge after U.S.-Iran strikes. Korea's KOSPI bears the brunt, signaling broad ris...
The S&P 500 faced renewed selling on March 24, 2026, as traders weighed higher yields and mixed earnings. The stock m...
A surge in AI infrastructure chips has lifted the Philadelphia Semiconductor Index, yet broad market participation is...
May data show five straight months of growth for U.S. manufacturers, marking the longest winning streak since 2022. Y...
In a dramatic 48-hour move, the world’s hottest stock market erased and then recovered a large portion of its gains, ...
Bitcoin weakens as the dollar strengthens, signaling tighter liquidity and renewed selling pressure. Analysts warn th...
Bitcoin dominance hits one-month as traders rotate into altcoins, signaling a leadership shift in the crypto market a...
Are patient investors finally getting a chance to weigh SpaceX as a long-term growth play? This guide explains how a ...
Over five years, SPDR’s XLK delivered a 35-point edge on the S&P 500, even as a Feb 2026 pullback tested investor ner...
Investors are tracing a familiar 1990 Gulf War playbook as oil climbs and energy shares outperform, while the broader...
Oil prices fall, stock futures rise as reports of a U.S.-backed cease-fire plan with Iran surface, setting up a cauti...